// about Insilico Medicine
Insilico Medicine uses generative AI and reinforcement learning to accelerate drug discovery. Its Chemistry42 platform designs novel drug molecules with desired properties in days rather than years. The company made history by advancing the first AI-designed drug candidate into Phase II clinical trials for idiopathic pulmonary fibrosis.
// related tools in Healthcare
Abridge
AI medical conversation summarisation for clinicians
Ada Health
AI symptom checker and health assessment tool
Aidoc
AI radiology platform for incidental finding detection
AlphaFold
DeepMind's AI that predicts protein structures
Babylon Health
AI-powered healthcare platform and virtual consultations
BenevolentAI
AI drug discovery platform for complex diseases